XML 61 R50.htm IDEA: XBRL DOCUMENT v3.21.1
Company-wide Realignments - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Restructuring Cost And Reserve [Line Items]    
Reversal of non-cash-stock-based compensation expense   $ 0.4
Restructuring costs   4.1
Tetraphase Pharmaceuticals, Inc.    
Restructuring Cost And Reserve [Line Items]    
Restructuring costs   $ 3.1
Payments for restructuring $ 2.5  
Accrued Payroll and Related Expenses | Tetraphase Pharmaceuticals, Inc.    
Restructuring Cost And Reserve [Line Items]    
Restructuring charges $ 0.6